Utility of Cerebral Microvascular Imaging in Infants Undergoing ECMO

Luis Octavio Tierradentro-Garcia1, Joseph A Stern1, Rebecca Dennis1,2

  • 1Department of Pediatric Radiology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Abstract

Insights

Microvascular imaging (MVI) can assess brain blood flow in infants on extracorporeal membrane oxygenation (ECMO). White matter vascular engorgement on MVI may predict poor outcomes in these high-risk infants.

Area of Science:

  • Neonatal neurology
  • Pediatric radiology
  • Cardiovascular imaging

Background:

  • Infants requiring extracorporeal membrane oxygenation (ECMO) face significant risks of neurological complications and mortality.
  • Advanced Doppler techniques like Microvascular Imaging (MVI) offer high-resolution visualization of cerebral microvasculature.

Purpose of the Study:

  • To evaluate the feasibility and utility of MVI for assessing cerebral microvascular perfusion in infants undergoing ECMO.
  • To explore the association between MVI findings and clinical outcomes in this vulnerable population.

Main Methods:

  • Retrospective analysis of brain MVI scans in neonates undergoing ECMO.
  • Qualitative assessment of MVI features including tortuosity, symmetry, heterogeneity, engorgement, and hypoperfusion in the basal ganglia-thalamus (BGT) region and cortex.
  • Correlation of MVI findings with clinical outcomes such as death, seizures, and cerebrovascular events.

Main Results:

  • Lenticulostriate vessel tortuosity was the most prevalent finding in the BGT region (86.7%).
  • Increased peri-gyral flow was the most common cortical finding (41.7%).
  • Cortical white matter vascular engorgement was significantly associated with poor outcomes (death, seizure, or cerebrovascular events; p = 0.03).

Conclusions:

  • Microvascular imaging (MVI) is a feasible method for evaluating cerebral perfusion in infants on ECMO.
  • White matter vascular engorgement identified by MVI may serve as a predictive marker for adverse outcomes in neonates undergoing ECMO therapy.